Name: Global Endoparasiticide Market Insights and Forecast to 2035
Brand: Extent Research
Price: 3500 USD
Availability: InStock
Rating: 4.7 (138 reviews)

Global Endoparasiticide Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

Report on the Global Endoparasiticide Market is a cradle for all the market-related details right from the finances, regional development to the future market growth rate. It also touches upon the market valuation which comprises of the market size, revenue, and share in order to be acquainted with the current market position on both the regional and global platform. To shed more light on the market growth rate, the report offers information such as recent developments, achievements, obstacles, threats, and market driving factors. The Global Endoparasiticide Market report provides information validated using few research methodologies and primary or secondary resources.

Data provided by Extent Research. Source: https://www.extentresearch.com/endoparasiticide-market

Key Players:

The dominating players in the Global Endoparasiticide Market include Boehringer Ingelheim, Elanco, Zoetis, Merck, Virbac, Novartis AG, Ceva Sante Animlae, Bayer AG, Eli Lilly, Vetoquinol, . The market players help understand the supply & demand ratio, consumer preferences, latest manufacturing process, and latest developments. The competitive landscape focuses more on the financial gains and market developments over the forecast period.

Segmentation of the Global Endoparasiticide Market:

By Product type

Ear Tags, Tablets, Injectables, Feed Additives,

by Application

Veterinary Hospitals or Clinics, Animal Farms, Home Care Settings,

Regional Study:

In the regional analysis, the report clarifies the market regional market attractiveness, industrial developments in specific regions, sales analysis, and other market segmentations. The regions including North America, Europe, Asia Pacific, Latin America, Middle East & Africa, offer excellent socio-economic environment for the Endoparasiticide industry development. It also confirms the market status on both the regional and global platform.

In this report, the experts have clearly extrapolated facets such as market driving factors, market revenue, share, size, opportunities & challenges, changing market dynamics, key players, dominating regions, economic instabilities, and other competitive factors.

COVID-19 Impact Analysis:

In the Global Endoparasiticide Market report, the experts have touched upon the pre- and post-COVID-19 impacts. The report elaborates the advantages as well as the disadvantages in terms of finance and market growth attained during this crisis. Despite, a major economic plunge, the Endoparasiticide Market has adopted new strategies and development skills to bounce back. The market has started looking for different funding sources and business approaches to sustain on both the regional and global platform.

Report Scope and Market Segmentation

ATTRIBUTES	Global Endoparasiticide Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global Endoparasiticide Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Study Coverage
    1.1 Endoparasiticide Product Introduction
    1.2 Market by Type
        1.2.1 Global Endoparasiticide Market Size Growth Rate by Type, 2017 VS 2021 VS 2035
        1.2.2 Ear Tags
        1.2.3 Tablets
        1.2.4 Injectables
        1.2.5 Feed Additives
    1.3 Market by Application
        1.3.1 Global Endoparasiticide Market Size Growth Rate by Application, 2017 VS 2021 VS 2035
        1.3.2 Veterinary Hospitals or Clinics
        1.3.3 Animal Farms
        1.3.4 Home Care Settings
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Endoparasiticide Sales Estimates and Forecasts 2017-2035
    2.2 Global Endoparasiticide Revenue Estimates and Forecasts 2017-2035
    2.3 Global Endoparasiticide Revenue by Region: 2017 VS 2021 VS 2035
    2.4 Global Endoparasiticide Sales by Region
        2.4.1 Global Endoparasiticide Sales by Region (2017-2022)
        2.4.2 Global Sales Endoparasiticide by Region (2023-2035)
    2.5 Global Endoparasiticide Revenue by Region
        2.5.1 Global Endoparasiticide Revenue by Region (2017-2022)
        2.5.2 Global Endoparasiticide Revenue by Region (2023-2035)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Endoparasiticide Sales by Manufacturers
        3.1.1 Global Top Endoparasiticide Manufacturers by Sales (2017-2022)
        3.1.2 Global Endoparasiticide Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Endoparasiticide in 2021
    3.2 Global Endoparasiticide Revenue by Manufacturers
        3.2.1 Global Endoparasiticide Revenue by Manufacturers (2017-2022)
        3.2.2 Global Endoparasiticide Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Endoparasiticide Revenue in 2021
    3.3 Global Endoparasiticide Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Endoparasiticide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Endoparasiticide Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Endoparasiticide Sales by Type
        4.1.1 Global Endoparasiticide Historical Sales by Type (2017-2022)
        4.1.2 Global Endoparasiticide Forecasted Sales by Type (2023-2035)
        4.1.3 Global Endoparasiticide Sales Market Share by Type (2017-2035)
    4.2 Global Endoparasiticide Revenue by Type
        4.2.1 Global Endoparasiticide Historical Revenue by Type (2017-2022)
        4.2.2 Global Endoparasiticide Forecasted Revenue by Type (2023-2035)
        4.2.3 Global Endoparasiticide Revenue Market Share by Type (2017-2035)
    4.3 Global Endoparasiticide Price by Type
        4.3.1 Global Endoparasiticide Price by Type (2017-2022)
        4.3.2 Global Endoparasiticide Price Forecast by Type (2023-2035)
5 Market Size by Application
    5.1 Global Endoparasiticide Sales by Application
        5.1.1 Global Endoparasiticide Historical Sales by Application (2017-2022)
        5.1.2 Global Endoparasiticide Forecasted Sales by Application (2023-2035)
        5.1.3 Global Endoparasiticide Sales Market Share by Application (2017-2035)
    5.2 Global Endoparasiticide Revenue by Application
        5.2.1 Global Endoparasiticide Historical Revenue by Application (2017-2022)
        5.2.2 Global Endoparasiticide Forecasted Revenue by Application (2023-2035)
        5.2.3 Global Endoparasiticide Revenue Market Share by Application (2017-2035)
    5.3 Global Endoparasiticide Price by Application
        5.3.1 Global Endoparasiticide Price by Application (2017-2022)
        5.3.2 Global Endoparasiticide Price Forecast by Application (2023-2035)
6 North America
    6.1 North America Endoparasiticide Market Size by Type
        6.1.1 North America Endoparasiticide Sales by Type (2017-2035)
        6.1.2 North America Endoparasiticide Revenue by Type (2017-2035)
    6.2 North America Endoparasiticide Market Size by Application
        6.2.1 North America Endoparasiticide Sales by Application (2017-2035)
        6.2.2 North America Endoparasiticide Revenue by Application (2017-2035)
    6.3 North America Endoparasiticide Market Size by Country
        6.3.1 North America Endoparasiticide Sales by Country (2017-2035)
        6.3.2 North America Endoparasiticide Revenue by Country (2017-2035)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Endoparasiticide Market Size by Type
        7.1.1 Europe Endoparasiticide Sales by Type (2017-2035)
        7.1.2 Europe Endoparasiticide Revenue by Type (2017-2035)
    7.2 Europe Endoparasiticide Market Size by Application
        7.2.1 Europe Endoparasiticide Sales by Application (2017-2035)
        7.2.2 Europe Endoparasiticide Revenue by Application (2017-2035)
    7.3 Europe Endoparasiticide Market Size by Country
        7.3.1 Europe Endoparasiticide Sales by Country (2017-2035)
        7.3.2 Europe Endoparasiticide Revenue by Country (2017-2035)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Endoparasiticide Market Size by Type
        8.1.1 Asia Pacific Endoparasiticide Sales by Type (2017-2035)
        8.1.2 Asia Pacific Endoparasiticide Revenue by Type (2017-2035)
    8.2 Asia Pacific Endoparasiticide Market Size by Application
        8.2.1 Asia Pacific Endoparasiticide Sales by Application (2017-2035)
        8.2.2 Asia Pacific Endoparasiticide Revenue by Application (2017-2035)
    8.3 Asia Pacific Endoparasiticide Market Size by Region
        8.3.1 Asia Pacific Endoparasiticide Sales by Region (2017-2035)
        8.3.2 Asia Pacific Endoparasiticide Revenue by Region (2017-2035)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Endoparasiticide Market Size by Type
        9.1.1 Latin America Endoparasiticide Sales by Type (2017-2035)
        9.1.2 Latin America Endoparasiticide Revenue by Type (2017-2035)
    9.2 Latin America Endoparasiticide Market Size by Application
        9.2.1 Latin America Endoparasiticide Sales by Application (2017-2035)
        9.2.2 Latin America Endoparasiticide Revenue by Application (2017-2035)
    9.3 Latin America Endoparasiticide Market Size by Country
        9.3.1 Latin America Endoparasiticide Sales by Country (2017-2035)
        9.3.2 Latin America Endoparasiticide Revenue by Country (2017-2035)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Endoparasiticide Market Size by Type
        10.1.1 Middle East and Africa Endoparasiticide Sales by Type (2017-2035)
        10.1.2 Middle East and Africa Endoparasiticide Revenue by Type (2017-2035)
    10.2 Middle East and Africa Endoparasiticide Market Size by Application
        10.2.1 Middle East and Africa Endoparasiticide Sales by Application (2017-2035)
        10.2.2 Middle East and Africa Endoparasiticide Revenue by Application (2017-2035)
    10.3 Middle East and Africa Endoparasiticide Market Size by Country
        10.3.1 Middle East and Africa Endoparasiticide Sales by Country (2017-2035)
        10.3.2 Middle East and Africa Endoparasiticide Revenue by Country (2017-2035)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Boehringer Ingelheim
        11.1.1 Boehringer Ingelheim Corporation Information
        11.1.2 Boehringer Ingelheim Overview
        11.1.3 Boehringer Ingelheim Endoparasiticide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Boehringer Ingelheim Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Boehringer Ingelheim Recent Developments
    11.2 Elanco
        11.2.1 Elanco Corporation Information
        11.2.2 Elanco Overview
        11.2.3 Elanco Endoparasiticide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Elanco Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Elanco Recent Developments
    11.3 Zoetis
        11.3.1 Zoetis Corporation Information
        11.3.2 Zoetis Overview
        11.3.3 Zoetis Endoparasiticide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Zoetis Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Zoetis Recent Developments
    11.4 Merck
        11.4.1 Merck Corporation Information
        11.4.2 Merck Overview
        11.4.3 Merck Endoparasiticide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Merck Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Merck Recent Developments
    11.5 Virbac
        11.5.1 Virbac Corporation Information
        11.5.2 Virbac Overview
        11.5.3 Virbac Endoparasiticide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Virbac Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Virbac Recent Developments
    11.6 Novartis AG
        11.6.1 Novartis AG Corporation Information
        11.6.2 Novartis AG Overview
        11.6.3 Novartis AG Endoparasiticide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Novartis AG Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Novartis AG Recent Developments
    11.7 Ceva Sante Animlae
        11.7.1 Ceva Sante Animlae Corporation Information
        11.7.2 Ceva Sante Animlae Overview
        11.7.3 Ceva Sante Animlae Endoparasiticide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Ceva Sante Animlae Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Ceva Sante Animlae Recent Developments
    11.8 Bayer AG
        11.8.1 Bayer AG Corporation Information
        11.8.2 Bayer AG Overview
        11.8.3 Bayer AG Endoparasiticide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Bayer AG Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Bayer AG Recent Developments
    11.9 Eli Lilly
        11.9.1 Eli Lilly Corporation Information
        11.9.2 Eli Lilly Overview
        11.9.3 Eli Lilly Endoparasiticide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Eli Lilly Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Eli Lilly Recent Developments
    11.10 Vetoquinol
        11.10.1 Vetoquinol Corporation Information
        11.10.2 Vetoquinol Overview
        11.10.3 Vetoquinol Endoparasiticide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Vetoquinol Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Vetoquinol Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Endoparasiticide Industry Chain Analysis
    12.2 Endoparasiticide Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Endoparasiticide Production Mode & Process
    12.4 Endoparasiticide Sales and Marketing
        12.4.1 Endoparasiticide Sales Channels
        12.4.2 Endoparasiticide Distributors
    12.5 Endoparasiticide Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Endoparasiticide Industry Trends
    13.2 Endoparasiticide Market Drivers
    13.3 Endoparasiticide Market Challenges
    13.4 Endoparasiticide Market Restraints
14 Key Findings in The Global Endoparasiticide Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global Endoparasiticide Market